Chloramphenicol levels in cerebrospinal fluid in meningitis

Area of Science:

• Pediatric Infectious Diseases
• Neuroscience
• Pharmacology

Background:

• Pyogenic meningitis is a serious infection affecting the central nervous system in children.
• Effective treatment requires antibiotics that can penetrate the blood-brain barrier.
• Haemophilus influenzae meningitis poses a significant risk to pediatric populations.

Purpose of the Study:

• To evaluate the efficacy of chloramphenicol in crossing the blood-brain barrier in pediatric patients with pyogenic meningitis.
• To determine the optimal timing for assessing chloramphenicol penetration into cerebrospinal fluid.
• To establish chloramphenicol's role in treating Haemophilus influenzae meningitis.

Main Methods:

• The study involved pediatric patients diagnosed with pyogenic meningitis.
• Cerebrospinal fluid samples were analyzed to measure chloramphenicol concentrations.
• Drug levels were assessed at specific time points during therapy (days 2 and 10).

Main Results:

• Chloramphenicol demonstrated effective penetration into the cerebrospinal fluid.
• Significant drug levels were observed in the cerebrospinal fluid on both day 2 and day 10 of treatment.
• The findings support the therapeutic utility of chloramphenicol in this patient group.

Conclusions:

• Chloramphenicol is a viable treatment option for pediatric pyogenic meningitis due to its blood-brain barrier penetration.
• The drug is recommended as a primary choice for managing Haemophilus influenzae meningitis in children.
• Further research may explore optimal dosing and long-term outcomes.